Lv31
268 积分 2025-09-03 加入
A dynamic map for learning, communicating, navigating and improving therapeutic development
5小时前
已完结
The present and future of bispecific antibodies for cancer therapy
21天前
已完结
GPCR drug discovery: new agents, targets and indications
27天前
已完结
cAMP-PKA signaling pathway and anxiety: Where do we go next?
27天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
1个月前
已完结
In vivo CAR engineering for immunotherapy
1个月前
已完结
From bench to body: In vivo CAR engineering in the clinic
1个月前
已完结
Targeting KAT6A/B as a New Therapeutic Strategy for Cancer Therapy
2个月前
已完结
The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology
2个月前
已完结
Baseline immune state and T-cell clonal kinetics are associated with durable response to CAR-T therapy in large B-cell lymphoma
4个月前
已完结
皖公网安备34019202002308
